GT Biopharma Inc.

11/06/2025 | Press release | Archived content

XBRL Q3 2025

Quarterly report [Sections 13 or 15(d)]

Cover

Cover - shares

9 Months Ended

Sep. 30, 2025

Nov. 06, 2025

Cover [Abstract]
Document Type 10-Q
Amendment Flag false
Document Quarterly Report true
Document Transition Report false
Document Period End Date Sep. 30, 2025
Document Fiscal Period Focus Q3
Document Fiscal Year Focus 2025
Current Fiscal Year End Date --12-31
Entity File Number 001-40023
Entity Registrant Name GT BIOPHARMA, INC.
Entity Central Index Key 0000109657
Entity Tax Identification Number 94-1620407
Entity Incorporation, State or Country Code DE
Entity Address, Address Line One 505 Montgomery Street
Entity Address, Address Line Two 10th Floor
Entity Address, City or Town San Francisco
Entity Address, State or Province CA
Entity Address, Postal Zip Code 94111
City Area Code 415
Local Phone Number 919-4040
Title of 12(b) Security Common Stock, $0.001 par value per share
Trading Symbol GTBP
Security Exchange Name NASDAQ
Entity Current Reporting Status Yes
Entity Interactive Data Current Yes
Entity Filer Category Non-accelerated Filer
Entity Small Business true
Entity Emerging Growth Company false
Entity Shell Company false
Entity Common Stock, Shares Outstanding 10,636,135
GT Biopharma Inc. published this content on November 06, 2025, and is solely responsible for the information contained herein. Distributed via Public Technologies (PUBT), unedited and unaltered, on November 14, 2025 at 21:29 UTC. If you believe the information included in the content is inaccurate or outdated and requires editing or removal, please contact us at [email protected]